Cytoflavin® is a metabolic drug. Its pharmacological effects are stipulated by the complex effect of the components that make up the drug: succinic acid, inosine, nicotinamide and riboflavin. 

  • Succinic acid is used in medication as an active substance, improving tissue metabolism and energy supply and reducing tissue hypoxia.
  • Ionzine increases the energy balance of the myocardium, improves the coronary circulation, prevents sequela of intraoperative renal ischemia. 
  • Nicotinamide treats vitamin deficiencies, has an anti-pellagric effect and participates in redox biochemical processes in cells. It does not cause unpleasant skin side effects.
  • Riboflavin is used to prevent and treat vitamin B2 deficiency, to treat skin diseases, sluggish wounds, eye diseases, gastrointestinal tract dysfunction, diabetes, anemia, and cirrhosis.
Cytoflavin® has beneficial effect on patient's neurologic status by reducing manifestations of asthenia, headache, vestibulocerebellar and cochlear-vestibular syndromes. 
When using Cytoflavin® in the first 12 hours after the onset of a stroke, a favorable course of ischemic and necrotic processes in the affected area (reduction of the decease focus) as well as restoration of neurological status and a decrease in the level of disability in the long-term period are observed.

The high content of useful active ingredients makes Cytoflavin® an effective drug in the treatment of the following diseases:

  • Neurasthenia (irritability, fatigue, loss of ability to perform mental and physical work);
  • Consequences of myocardial infarction;
  • Hypertensive encephalopathy;
  • Chronic cerebrovascular disease.


Dosage and Administration

Per os, 2 tab. 2 times / day, 30 minutes before meals, without chewing with an interval of 8-10 hours (drink 100 ml of water). The duration of the course is 25 days (100 tablets). An evening intake of the drug should not be later than at 6pm.

The course cannot be repeated earlier than 25-30 days after the end of the previous course.


Cytoflavin® is used with caution in case of gout, nephrolithiasis and hyperuricemia. The manufacturer's instruction highlights a number of direct contraindications:

  • Intolerance to the drug components;
  • Pregnancy and lactation.

Side Effects

In case of prolonged use in high doses: transient hypoglycemia, hyperuricemia and exacerbation of gout (possible).



When Cytoflavin® is taken orally, dose adjustment of antihypertensive drugs in patients with arterial hypertension may be required.

The drug therapy is performed with caution in case of diabetes. During the treatment, plasma glucose should be monitored.

When using the drug, urine staining in yellow is possible.